Filter
467
Text search:
antiretrovirals
Featured
Recommendations
24
New Publications
88
Language
Document type
No document type
326
Studies & Reports
53
Guidelines
44
Manuals
20
Infographics
11
Fact sheets
6
Training Material
3
Strategic & Response Plan
3
Online Courses
1
Countries / Regions
Kenya
19
Zambia
15
South Africa
15
Latin America and the Carribbean
15
Malawi
13
Rwanda
11
Nigeria
9
Uganda
9
Africa
9
Zimbabwe
8
Namibia
8
Global
8
Mozambique
7
Lesotho
7
Asia
7
Liberia
6
Ghana
6
India
6
Tanzania
6
Senegal
5
Cambodia
5
East and Southern Africa
5
Venezuela
5
Sierra Leone
4
Congo, Democratic Republic of
4
Ethiopia
4
Nepal
4
South–East Asia Region
4
Cameroon
3
Haiti
3
Philippines
3
Indonesia
3
Eswatini/ Swaziland
3
Brazil
3
Ukraine
3
Botswana
3
West and Central Africa
3
Russia
3
Burkina Faso
2
Thailand
2
Bangladesh
2
Benin
2
Central African Republic
2
Argentina
2
North Macedonia
2
Colombia
2
Angola
2
Myanmar / Burma
2
Middle East and North Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Western and Central Europe
2
Albania
2
Georgia
2
Guinea
1
Mali
1
Guinea-Bissau
1
Germany
1
Peru
1
Bolivia
1
Libya
1
Chile
1
Other region
1
Paraguay
1
Eastern Europe
1
Laos
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
186
Clinical Guidelines
41
Women & Child Health
19
Public Health
10
Key Resources
5
Pharmacy & Technologies
5
Capacity Building
3
Toolboxes
HIV
176
TB
32
Pharmacy
30
COVID-19
24
Caregiver
8
Mental Health
7
AMR
7
NTDs
3
Disability
2
Ebola
2
Conflict
2
Social Ethics
2
Health Financing Toolbox
2
Refugee
1
Global Health Education
1
Health Financing
1
NCDs
1
PLOS ONE | https://doi.org/10.1371/journal.pone.0183180 October 9, 2017
Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission—
A Working Group of the Office of AIDS Research Advisory Council (OARAC)
Accessed: 12.02.2020
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS preventio
...
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and e
...
guidance for health managers, health workers, and activists
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start
...
This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing thirty key questions about PrEP and how it might be implemented in the UK.
The module is currently available in English, French, Nepali, Portuguese, Russian, and Spanish
PLoS One. 2012; 7(4): e29656.
Published online 2012 Apr 20. doi: 10.1371/journal.pone.0029656
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
National Guidelines for HIV & AIDS Care and Treatment (5th Edition)
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
